Gene · 28695
Papers3,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TIGIT reverses IFN-α-promoted Th1-like Tregs via in-sequence effects dependent on STAT4. | Arthritis Res Ther | 2023 | 37978415 | PubTator, text mining | PubMed |
| Human tumor viruses: induction of three-dimensional alterations in the host genome structure. | Front Microbiol | 2023 | 37928671 | PubTator, text mining | PubMed |
| Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia. | Front Immunol | 2023 | 37928542 | PubTator, text mining | PubMed |
| Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire. | PLoS One | 2023 | 37922286 | PubTator, text mining | PubMed |
| Both Horatio and Polonius: Innate Lymphoid Cells in Tissue Homeostasis and Repair. | Immunohorizons | 2023 | 37916861 | PubTator, text mining | PubMed |
| Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans. | Front Immunol | 2023 | 37908349 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Peritoneal Cells Reveals the Early Immune Response of Flounder (Paralichthys olivaceus) to Inactivated Vibrio anguillarum Immunization. | Vaccines (Basel) | 2023 | 37897005 | PubTator, text mining | PubMed |
| T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy. | Int J Mol Sci | 2023 | 37894892 | PubTator, text mining | PubMed |
| Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring. | Cancers (Basel) | 2023 | 37894301 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| High-throughput data and modeling reveal insights into the mechanisms of cooperative DNA-binding by transcription factor proteins. | Nucleic Acids Res | 2023 | 37889068 | PubTator, text mining | PubMed |
| T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T cells with specificities against immunogenic viral antigens. | Cell Rep | 2023 | 37883974 | PubTator, text mining | PubMed |
| Impaired T cell IRE1α/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction. | J Clin Invest | 2023 | 37874641 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. | Nat Commun | 2023 | 37872153 | PubTator, text mining | PubMed |
| Screening single-cell trajectories via continuity assessments for cell transition potential. | Brief Bioinform | 2023 | 37864296 | PubTator, text mining | PubMed |
| Conserved biophysical compatibility among the highly variable germline-encoded regions shapes TCR-MHC interactions. | Elife | 2023 | 37861280 | PubTator, text mining | PubMed |
| AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo. | iScience | 2023 | 37860759 | PubTator, text mining | PubMed |
| Determining epitope specificity of T-cell receptors with transformers. | Bioinformatics | 2023 | 37847663 | PubTator, text mining | PubMed |
| Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications. | Genome Med | 2023 | 37845772 | PubTator, text mining | PubMed |
| Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial. | JAMA Oncol | 2023 | 37824131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28695/papers?page=8